ARYX
ARYx Therapeutics, Inc.

38
Loading...
Loading...
ARYx Therapeutics, Inc. discovers and develops drugs for large, chronic disease markets. Its products include Naronapride, a proprietary serotonin type 4 (5HT4) for the treatment of multiple gastrointestinal disorders, Budiodarone, a proprietary compound in Phase 2 development for the treatment of atrial fibrillation, Tecarfarin, a novel compound for oral anti-coagulation therapy, and ATI-9242, a typical antipsychotic for the treatment of schizophrenia and other psychiatric disorders. The company was founded on February 28, 1997 by Peter G. Milner and Pascal Druzgala and is headquartered in Fremont, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Aryx Therapeutics Inc?
What is the 52-week high for Aryx Therapeutics Inc?
What is the 52-week low for Aryx Therapeutics Inc?
What is the 50-day moving average of Aryx Therapeutics Inc?

Latest ARYX News

View
No ARYX news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.